Skip to main content
. 2016 Apr 19;47(3):531–535. doi: 10.1016/j.bjm.2016.01.029

Table 2.

Characteristics of CF patients.

Patient code Age (years)/sex Nocardia species Accompanying pathogens Clinical significance Antibiotic treatment Clinical evolution
1 11/F N. farcinica S. aureus, H. influenzae Chronic colonizationa, pneumonia TMP-SMX, AMC Bronchiectasis
2 17/F N. farcinica P. aeruginosa, S. apiospermum Colonization TMP-SMX No worsening
3 10/F N. farcinica S. aureus, P. aeruginosa Pneumonia AMK, TMP-SMX Severe bronchiectasis.
Worsening
4 11/M N. transvalensis S. aureus, P. aeruginosa Chronic colonization TMP-SMX Dead 1998.
Massive hemoptysis
5 10/F N. transvalensis S. aureus, P. aeruginosa Chronic colonization TMP-SMX Severe bronchiectasis.
Worsening
6 16/M N. veterana S. aureus, P. aeruginosa Transient colonizationb None No worsening
7 15/F N. pneumoniae S. aureus, S. apiospermum Transient colonization None No worsening
8 16/F N. wallacei P. aeruginosa, A. fumigatus Transient colonization AMC No worsening

F, female; M, male; TMP-SMX, trimethoprim-sulfamethoxazole; AMC, amoxicillin-clavulanic acid; AMK, amikacin.

a

Chronic colonization: Nocardia detected three or more times in six months.

b

Transient colonization: Nocardia detected occasionally in one or two cultures in six months.